Healthcare provider profile · identity verified

Maurice Eugene Nida, DO

Internal Medicine · NORTON, VA · NPI 1285601344

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Levothyroxine Sodium	Levothyroxine Sodium	225	43
Lisinopril	Lisinopril	219	49
Losartan Potassium	Losartan Potassium	202	54
Metformin Hcl	Metformin Hcl	188	45
Pantoprazole Sodium	Pantoprazole Sodium	186	45
Atorvastatin Calcium	Atorvastatin Calcium	181	49
Rosuvastatin Calcium	Rosuvastatin Calcium	166	48
Gabapentin	Gabapentin	157	31
Omeprazole	Omeprazole	128	30
Jardiance	Empagliflozin	116	21
Amlodipine Besylate	Amlodipine Besylate	115	33
Albuterol Sulfate Hfa	Albuterol Sulfate	106	23
Eliquis	Apixaban	106	22
Furosemide	Furosemide	105	29
Tamsulosin Hcl	Tamsulosin Hcl	103	26
Montelukast Sodium	Montelukast Sodium	100	24
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	90	23
Potassium Chloride	Potassium Chloride	81	21
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	78	17
Simvastatin	Simvastatin	78	17
Ozempic	Semaglutide	77	13
Pravastatin Sodium	Pravastatin Sodium	72	17
Carvedilol	Carvedilol	70	22
Escitalopram Oxalate	Escitalopram Oxalate	69	17
Fluticasone Propionate	Fluticasone Propionate	69	20
Metoprolol Tartrate	Metoprolol Tartrate	68	17
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	65	14
Duloxetine Hcl	Duloxetine Hcl	62	11
Buspirone Hcl	Buspirone Hcl	61	suppressed
Hydrochlorothiazide	Hydrochlorothiazide	57	13
Famotidine	Famotidine	54	16
Tizanidine Hcl	Tizanidine Hcl	54	suppressed
Lorazepam	Lorazepam	52	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	51	suppressed
Metoprolol Succinate	Metoprolol Succinate	51	18
Isosorbide Mononitrate Er	Isosorbide Mononitrate	48	11
Warfarin Sodium	Warfarin Sodium	48	suppressed
Clopidogrel	Clopidogrel Bisulfate	47	13
Ondansetron Hcl	Ondansetron Hcl	45	13
Prednisone	Prednisone	44	16
Ropinirole Hcl	Ropinirole Hcl	43	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	41	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	39	12
Tramadol Hcl	Tramadol Hcl	37	suppressed
Metformin Hcl Er	Metformin Hcl	36	12
Alendronate Sodium	Alendronate Sodium	33	suppressed
Meloxicam	Meloxicam	33	15
Januvia	Sitagliptin Phosphate	32	suppressed
Mounjaro	Tirzepatide	32	suppressed
Ventolin Hfa	Albuterol Sulfate	30	suppressed
Clonazepam	Clonazepam	28	suppressed
Finasteride	Finasteride	28	suppressed
Pregabalin	Pregabalin	28	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	27	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	27	suppressed
Spironolactone	Spironolactone	27	suppressed
Citalopram Hbr	Citalopram Hydrobromide	26	suppressed
Allopurinol	Allopurinol	25	suppressed
Baclofen	Baclofen	25	suppressed
Fluconazole	Fluconazole	25	suppressed
Hydralazine Hcl	Hydralazine Hcl	25	suppressed
Ondansetron Odt	Ondansetron	25	11
Mirtazapine	Mirtazapine	24	suppressed
Trazodone Hcl	Trazodone Hcl	24	suppressed
Ibuprofen	Ibuprofen	23	suppressed
Janumet	Sitagliptin Phos/Metformin Hcl	23	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	23	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	22	suppressed
Sildenafil Citrate	Sildenafil Citrate	22	suppressed
Humalog	Insulin Lispro	21	suppressed
Hydroxyzine Pamoate	Hydroxyzine Pamoate	21	suppressed
Aripiprazole	Aripiprazole	20	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	20	suppressed
Ezetimibe	Ezetimibe	19	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	19	suppressed
Topiramate	Topiramate	19	suppressed
Xarelto	Rivaroxaban	19	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	18	suppressed
Rizatriptan	Rizatriptan Benzoate	18	suppressed
Azithromycin	Azithromycin	17	12
Celecoxib	Celecoxib	17	suppressed
Amoxicillin	Amoxicillin	16	suppressed
Bupropion Hcl Sr	Bupropion Hcl	16	suppressed
Bupropion Xl	Bupropion Hcl	16	suppressed
Dropsafe Prep Pads	Alcohol Antiseptic Pads	16	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	16	suppressed
Lovastatin	Lovastatin	16	suppressed
Methocarbamol	Methocarbamol	16	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	16	suppressed
Sotalol	Sotalol Hcl	16	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	16	suppressed
Promethazine Hcl	Promethazine Hcl	15	suppressed
Symbicort	Budesonide/Formoterol Fumarate	15	suppressed
Atenolol	Atenolol	14	suppressed
Breyna	Budesonide/Formoterol Fumarate	14	suppressed
Hydrocortisone	Hydrocortisone	14	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	14	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	14	suppressed
Diclofenac Sodium	Diclofenac Sodium	13	suppressed
Levetiracetam	Levetiracetam	13	suppressed
Methotrexate	Methotrexate Sodium	13	suppressed
Nitroglycerin	Nitroglycerin	13	suppressed
Rybelsus	Semaglutide	13	suppressed
Spiriva Handihaler	Tiotropium Bromide	13	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	13	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	12	suppressed
Insulin Lispro Protamine Mix	Insulin Lispro Protamin/Lispro	12	suppressed
Irbesartan	Irbesartan	12	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	12	suppressed
Olanzapine	Olanzapine	12	suppressed
Terazosin Hcl	Terazosin Hcl	12	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	12	suppressed
Valsartan	Valsartan	12	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	12	suppressed
Ziprasidone Hcl	Ziprasidone Hcl	12	suppressed
Glimepiride	Glimepiride	11	suppressed
Paroxetine Hcl	Paroxetine Hcl	11	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	11	suppressed
Risperidone	Risperidone	11	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error